Compounds > carbon monoxide

carbon monoxide and mycophenolic acid

carbon monoxide has been researched along with mycophenolic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amberger, C; Fierlbeck, G; Henes, JC; Horger, M; Kanz, L; Koetter, I; Schmalzing, M1
Brown, KK; Chartrand, S; Fischer, A; Lee, JS; Stanchev, L; Swigris, JJ1
Aravena, C; Collard, HR; Dubé, BP; Elicker, BM; Fell, CD; Johannson, KA; Jones, KD; Ley, B; Manganas, H; Morisset, J; Ryerson, CJ; Vittinghoff, E; Wolters, PJ1
Béhal, H; Duhamel, A; Faivre, JB; Hachulla, AL; Hachulla, E; Hatron, PY; Lambert, M; Launay, D; Le Gouellec, N; Matran, R; Morell-Dubois, S; Perez, T; Remy-Jardin, M; Sobanski, V1
Arami, S; Clements, PJ; Elashoff, RM; Furst, DE; Goldmuntz, E; Hsu, V; Keyes-Elstein, L; Khanna, D; Li, N; Pinckney, A; Roth, MD; Schraufnagel, DE; Sim, M; Steen, V; Sullivan, KM; Tashkin, DP; Volkmann, ER1
Fiddler, CA; Parfrey, H; Simler, N; Thillai, M1

Trials

1 trial(s) available for carbon monoxide and mycophenolic acid

ArticleYear
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.
    Annals of the rheumatic diseases, 2019, Volume: 78, Issue:1

    Topics: Adult; Carbon Monoxide; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Pulmonary Diffusing Capacity; Risk Factors; Scleroderma, Systemic; Skin; Time Factors; Treatment Outcome; Vital Capacity

2019

Other Studies

5 other study(ies) available for carbon monoxide and mycophenolic acid

ArticleYear
Enteric-coated mycophenolate sodium for progressive systemic sclerosis--a prospective open-label study with CT histography for monitoring of pulmonary fibrosis.
    Clinical rheumatology, 2013, Volume: 32, Issue:5

    Topics: Adult; Aged; Carbon Monoxide; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Pulmonary Fibrosis; Respiratory Function Tests; Scleroderma, Diffuse; Skin; Tablets, Enteric-Coated; Time Factors; Tomography, X-Ray Computed

2013
Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience.
    Respiratory medicine, 2016, Volume: 119

    Topics: Adrenal Cortex Hormones; Adult; Amino Acyl-tRNA Synthetases; Antibodies, Antinuclear; Autoimmune Diseases; Biopsy; Carbon Monoxide; Connective Tissue Diseases; Diagnosis, Differential; Enzyme Inhibitors; Female; Humans; Idiopathic Interstitial Pneumonias; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Mycophenolic Acid; Phenotype; Pulmonary Diffusing Capacity; Respiratory Function Tests; Retrospective Studies; Tomography, X-Ray Computed; Vital Capacity

2016
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.
    Chest, 2017, Volume: 151, Issue:3

    Topics: Aged; Alveolitis, Extrinsic Allergic; Azathioprine; Carbon Monoxide; Chronic Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Linear Models; Male; Middle Aged; Mycophenolic Acid; Prednisone; Pulmonary Diffusing Capacity; Retrospective Studies; Treatment Outcome; Vital Capacity

2017
Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
    PloS one, 2017, Volume: 12, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Monoxide; Cyclophosphamide; Diffusion; Echocardiography; Female; Fingers; Follow-Up Studies; Humans; Hypertension, Pulmonary; Linear Models; Lung; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pulmonary Diffusing Capacity; Respiratory Function Tests; Scleroderma, Systemic; Ulcer; Young Adult

2017
Use of mycophenolate mofetil and azathioprine for the treatment of chronic hypersensitivity pneumonitis-A single-centre experience.
    The clinical respiratory journal, 2019, Volume: 13, Issue:12

    Topics: Adrenal Cortex Hormones; Aged; Alveolitis, Extrinsic Allergic; Azathioprine; Carbon Monoxide; Chronic Disease; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Pulmonary Diffusing Capacity; Respiratory Function Tests; Retrospective Studies; Vital Capacity

2019